Healthtech & Wellness VC Funds

Batterson Venture Capital (BVC), now operating as VCapital, is a Chicago-based venture capital firm founded in 1995 by Len Batterson. The firm targets entrepreneurial seed, startup, and early-stage companies needing $500,000 to $5 million — deliberately filling what Batterson identified as the widely neglected funding gap that at the time received only 6% of all venture capital. Batterson previously founded Batterson, Johnson & Wang, the first Chicago-based early-stage technology and medical institutional VC fund, establishing his reputation as a pioneer of Midwest venture investing. The firm has backed 29 companies across software, health technology, clean technology, media, biotech, edtech, and data analytics. Notable exits include Cleversafe, acquired by IBM for $1.3 billion; Cybersource, acquired by Visa; Health Magazine, acquired by AOL/Time Warner; and Padcaster. Other portfolio companies include Beyond.com, Allscripts, and Illinois Superconductor Corporation. Checks average $1.5 million and range up to $5 million at pre-seed through Series A stages, with a focus on US companies and the Midwest in particular. Batterson Venture Capital's legacy is its role in establishing early-stage institutional venture capital in Chicago and the broader Midwest at a time when the region was largely bypassed by coastal funds. Len Batterson's successive firms — spanning three decades of early-stage investing — helped build the infrastructure, track record, and investor confidence that enabled the Chicago tech ecosystem to mature. The firm's continued operation as VCapital reflects the durability of its founding thesis: that underserved early-stage companies in non-coastal markets represent a genuine and repeatable investment opportunity.

Battery Ventures, founded in 1983, is a global, technology-focused investment firm with offices in Boston, San Francisco, Menlo Park, New York, London, and Tel Aviv. The firm has invested in over 450 companies, with 69 going public and 185 achieving mergers or acquisitions. Notable portfolio companies include AuditBoard, Nutanix, and Amplitude. Battery Ventures invests across various sectors, including application software, infrastructure software, consumer tech, industrial technologies, and life sciences. The firm's geographic reach and industry diversity allow it to support a wide range of innovative businesses. The investment strategy at Battery Ventures emphasizes both early and growth-stage companies, with a particular focus on majority-growth investments, where they take substantial ownership stakes. This approach helps them provide significant strategic and operational support to their portfolio companies. Battery's typical investments range from seed funding to large buyouts, with recent funds totaling over $3.8 billion. Key team members include Neeraj Agrawal, Michael Brown, and Roger Lee, all of whom bring extensive expertise in scaling technology companies. Their offices span major global tech hubs, ensuring a broad and influential presence in the venture capital landscape. For startups looking to connect with Battery Ventures, demonstrating robust market potential and strategic alignment with Battery’s focus areas can be advantageous. The firm values long-term partnerships and provides not just capital but also strategic guidance to help companies achieve substantial growth.

Battle Born Venture is Nevada’s state-sponsored venture capital program, established to support high-growth startups and diversify the state’s economy. Funded through the State Small Business Credit Initiative (SSBCI), it focuses on making equity and equity-like investments in early-stage companies that have the potential for significant impact in Nevada. Launched in 2014, Battle Born Venture has invested in a diverse range of sectors, including software, healthcare, consumer brands, and fintech. The program typically co-invests alongside other professional venture capital firms, such as Greycroft Partners, and has supported university spinouts and startups linked to Nevada’s research institutions. To qualify for funding, companies must be headquartered in Nevada, be for-profit entities, and demonstrate a scalable business model. Battle Born Venture usually invests up to $1 million over the life of a company, with an initial cap of $500,000 per round. Their investments are sector-agnostic, although they do avoid industries like gambling, alcohol, and firearms. The program is particularly focused on supporting startups at the seed or Series A stages, but it also considers pre-seed companies, especially those connected to Nevada’s universities or supported by the state’s Knowledge Fund. Battle Born Venture's involvement is crucial for startups looking to attract further investment and scale their operations, helping to solidify Nevada's growing startup ecosystem.

Baukunst is a venture capital firm dedicated to leading pre-seed investments in companies at the intersection of technology and design. With its inaugural $100 million fund, Baukunst focuses on partnering with creative technologists, often making the first institutional investment that a founding team receives. The firm typically invests between $500,000 and $2 million, aiming to lead every round and take an active role in building companies from the ground up. Baukunst's investment strategy emphasizes high conviction and deep engagement, offering more than just capital. The firm provides hands-on support during the critical early stages of company development, helping with hiring, customer acquisition, and product launch. Their portfolio spans diverse industries, including AI-powered platforms, sustainable energy solutions, and digital health technologies. Led by four general partners with extensive experience in building companies, Baukunst prioritizes companies that push the boundaries of innovation. Their portfolio includes startups like Omnibus (a digital comic platform), DIG Energy (affordable geothermal energy), and Eyebot (AI-driven eye exams). By investing in the early, formative stages, Baukunst partners with founders to transform bold ideas into enduring companies.

Baxter Ventures is the corporate venture capital arm of Baxter International Inc., a global medical technology company with over 85 years of healthcare innovation history. Founded in 2011 and based in Deerfield, Illinois, the firm invests in companies developing innovative technologies, products, and therapies that advance patient care. Investment areas encompass therapeutic applications complementary to Baxter's presence in critical care, hospital care, nutritional care, renal care, and surgical care, as well as cutting-edge technologies outside the parent's existing product portfolio. The firm targets Series A through later-stage rounds, typically writing checks between $3 million and $25 million, and has made 30 investments across health technology, biotech, pharma, hardware, and software. Portfolio companies include VitalConnect (wearable biosensors), Hospital IQ (hospital operations platform), Medasense (pain monitoring), Covagen (biopharmaceuticals, acquired by Johnson & Johnson), SANIFIT (calcification therapeutics), and ProMedix. Each investment undergoes rigorous evaluation for its potential to address unmet clinical needs and deliver long-term sustainable growth. Baxter Ventures supports founders by connecting them to Baxter International's global distribution channels, clinical development expertise, and commercial infrastructure. Backed by a parent company with approximately $15 billion in annual revenues, portfolio companies gain access to a uniquely scaled corporate partner capable of accelerating market adoption in hospital and clinical settings across the United States and Europe.

Bayern Kapital, founded in 1995 and based in Landshut, Germany, is a key venture capital firm focused on supporting high-tech startups and scale-ups in Bavaria. With nearly 30 years of experience, the firm manages around €700 million and has invested in over 320 Bavarian high-tech companies. Bayern Kapital offers investments ranging from €250,000 to €25 million per company, targeting sectors such as biotechnology, medical technology, software and IT, environmental technology, and new materials. The firm's investment approach emphasizes long-term partnerships, acting as a co-investor alongside private investors to support startups through various growth phases from seed to scale-up. Bayern Kapital prides itself on fostering innovation and entrepreneurship in Bavaria, aiming to drive job creation and economic development in the region. Some notable investments in their portfolio include companies like ProGlove, Immunic Therapeutics, and Sphera. Bayern Kapital's strategy is to offer not just financial support but also leverage their extensive network to help startups connect with potential investors, partners, and customers, thereby enhancing their growth prospects. Key team members include Wolfgang Härtl, Investment Director, who leads their dedicated team of over 40 professionals with diverse academic and professional backgrounds, contributing to their robust support system for portfolio companies​.

BBG Ventures is a New York-based venture capital fund that focuses on early-stage investments in women-led technology companies. The firm, which evolved from AOL's #BUILTBYGIRLS initiative, aims to support and inspire women and girls in the tech economy. BBG Ventures was founded in 2014 and is committed to backing diverse founders who are creating consumer applications and services that make lives simpler, better, and more enjoyable​. BBG Ventures targets sectors such as consumer technology, FinTech, and healthcare, with typical investments ranging from $500,000 to $1 million. They lead or co-lead Seed and Pre-Seed rounds, supporting founders who have a deep, intuitive understanding of the problems they aim to solve​. Notable investments include companies like Zola, Modsy, Spring Health, Blueland, Lola, Starface, and Pymetrics. The fund is led by a team dedicated to fostering innovation and supporting underrepresented entrepreneurs. They provide more than just capital, offering strategic guidance and leveraging their extensive network to help founders succeed​.

BCF Ventures, established in 2018, is a Montreal-based corporate venture capital fund that primarily invests in early-stage technology companies across North America, with selective investments in Europe and Israel. BCF Ventures was founded as a spin-off from BCF Business Law, one of Canada's leading law firms, making it one of the first Canadian venture funds launched by a law firm. BCF Ventures focuses on sectors such as B2B SaaS, cloud computing, artificial intelligence, and healthtech. The firm typically participates in Seed and Series A rounds, with initial check sizes around $125K, and prefers to be a minority investor, retaining pro-rata rights for future follow-on investments. Their investments often range from $1M to $5M in funding rounds, targeting companies with strong unit economics and modest revenue growth. Notable investments include companies like FleetOps in transportation tech, Athennian in enterprise applications, and FightCamp in healthtech. The firm is led by CEO Sergio Escobar and focuses on helping startups scale effectively while maintaining a lean cash burn and achieving at least 18 months of runway per funding round. BCF Ventures has garnered recognition for its diverse portfolio and strategic partnerships, leveraging its ties to BCF Law to offer startups both legal expertise and access to a broad network of industry connections, helping them navigate complex business landscapes as they scale.

BCG Digital Ventures (BCGDV) is the corporate innovation and digital business-building arm of Boston Consulting Group, founded in January 2014 and headquartered in Manhattan Beach, California. The firm collaborates with established corporations worldwide to invent, build, and scale new digital businesses, products, and platforms from the ground up. Operating 16 Innovation Centers and Labs across cities including Berlin, London, New York, Paris, Shanghai, Singapore, Sydney, and Tokyo, BCGDV brings a genuinely global footprint to its work. Since inception, BCGDV has launched more than 80 businesses and invested in 39 companies, leading rounds across seed through Series B stages with checks typically between $3 million and $25 million. The firm leads rounds and has backed companies across enterprise software, AI and data analytics, e-commerce, health technology, and transportation. Notable portfolio companies include Skoove (music education), SOL-X (workplace safety), Matmatch (materials marketplace), LabTwin (lab assistant AI), MachineMax (equipment monitoring), Sypht (document intelligence), and UP42 (geospatial data), the last of which was among 11 portfolio acquisitions including those by Maersk and HeyCar. BCGDV differentiates by embedding BCG's global client network, strategic consulting capabilities, and access to corporate partners directly into the company-building process. This model allows portfolio ventures to launch with enterprise customers already engaged, shortening the path from concept to commercial scale and providing a structural advantage that purely financial investors cannot replicate.

The Thrive Venture Fund is the direct-investment vehicle within BDC Capital's Thrive Platform for Women, a $500M investment platform launched in 2022 and described as the largest of its kind in the world, created to close the equity gap faced by women-led companies in Canada. The platform comprises the $300M Thrive Venture Fund, a $100M indirect investment envelope that backs other funds, and the $100M Thrive Lab for equity and equity-like investments in women-led social-impact businesses. Operated by BDC, the Business Development Bank of Canada, the Thrive Venture Fund makes direct equity investments in women-led Canadian technology companies at the seed and Series A and B stages, remaining sector agnostic while targeting businesses with strong growth and scalable market potential, and it is willing to lead. It builds on the firm's pioneering Women in Technology (WIT) Venture Fund, which made 38 investments and recorded successful exits including Beanworks, Kira Talent, Unsplash and Nudge. The fund is led by Managing Partner Mona Minhas, who succeeded long-time women's-fund leader Michelle Scarborough, with partners Steven Abrams, Thomas Green and Kimberly Yeung. Portfolio companies span AI, biotech, health, robotics and consumer sectors and include Waabi in autonomous driving, Sanctuary AI in humanoid robotics, SRTX/Sheertex in advanced textiles, Bridgit in construction tech, Eli Health, Private AI, Omy Laboratoires, Congruence Therapeutics, Radiant Biotherapeutics and Puzzle Medical. By dedicating significant institutional capital to women-led companies, the Thrive Venture Fund works to close Canada's gender-equity gap in venture funding.

BDMI (Bertelsmann Digital Media Investments) is the venture capital arm of Bertelsmann, based in New York City. The firm focuses on early-stage investments, managing both a seed fund and a traditional early-stage fund. BDMI typically invests between $500,000 to $5 million in sectors such as B2B, fintech, consumer, and media. For their seed fund, BDMI looks for products or services that are already live in the marketplace with early signs of product-market fit. They generally do not lead seed stage investments but prefer to join syndicates with a lead investor already in place. This strategy allows them to leverage the expertise of lead investors while providing crucial early-stage funding. BDMI’s notable investments include companies like Fatherly, Suzy, Inverse, DramaFever, Food52, and BarkBox. These investments reflect the firm’s commitment to backing innovative companies that are disrupting their respective industries. BDMI’s connection to Bertelsmann provides their portfolio companies with access to a vast network of resources and industry expertise, helping them scale and succeed in competitive markets. The firm prides itself on supporting its portfolio companies beyond just financial investment. By leveraging Bertelsmann's extensive network and resources, BDMI offers strategic guidance and operational support, helping startups navigate challenges and achieve their growth objectives. This holistic approach to venture capital makes BDMI a valuable partner for startups looking to make a significant impact in the digital media landscape.

BeAble Capital, established in 2016 and headquartered in Madrid, Spain, focuses on early-stage investments in deep science and industrial technologies. Their primary mission is to advance technologies from academic and research institutions into market-ready products, aligning with the United Nations Sustainable Development Goals. BeAble Capital's investment sectors include New Space, New Energy, New Materials, Agro & Food, Environment, Healthcare & Wellbeing, Medtech, Robotics, and AI. Notable investments in their portfolio include companies like Alen Space, which develops small satellites, and A4Cell, which specializes in single-cell monitoring tools. Another significant investment is in Alcyon Photonics, a firm that designs and manufactures photonic integrated circuits. BeAble Capital is led by founders Almudena Trigo, David López, and other partners. They emphasize a hands-on approach in the early development stages, including proof of concept, scale-up, and pre-industrial phases, providing critical support to transform scientific discoveries into commercially viable products. Their strategy involves close collaboration with universities, research centers, and industrial companies to identify promising projects, focusing on technologies that address unmet needs in high-growth markets. The firm has made over 50 investments, reflecting its commitment to fostering innovation and industrial growth in Spain and beyond.

Beast Ventures is a venture capital firm based in London, focusing on early-stage investments in deep tech and transformative technologies. Established in 2015, Beast Ventures targets startups across the UK and Continental Europe that are working on breakthrough engineering, applied science, and technology (hence the acronym BEAST). The firm emphasizes investments in frontier technologies that hold the potential for significant impact in areas such as health, climate, and society. Beast Ventures typically invests at the seed stage, providing support to founders from the inception of their companies through various stages of growth. The firm’s investment portfolio spans diverse industries including artificial intelligence, biotech, cybersecurity, climate tech, and more. Notable investments include companies like Ochre Bio, which focuses on developing RNA therapies for liver disease, and Nutropy, a biotech startup creating sustainable food products. The fund's investment strategy is geared towards achieving outsized returns by backing startups that push the boundaries of science and technology, particularly those with the potential to create significant societal impact. Beast Ventures offers flexible investment sizes, ranging from $100,000 to $2 million, and is known for its deep commitment to supporting cutting-edge innovation​.

BECO Capital is a leading early-stage venture capital firm based in Dubai, focused on fostering technology-driven startups in the Middle East and North Africa (MENA) region. Founded in 2012, BECO Capital has become one of the largest non-governmental VCs in MENA, managing $486 million in assets across four funds. The firm is known for its hands-on approach, providing both capital and strategic operational support to help early-stage companies scale and thrive. BECO Capital has built a strong track record, backing some of the region’s most successful startups, including Careem (acquired by Uber for $3.1 billion), Property Finder, and Kitopi. These investments have led to multiple unicorn exits, reinforcing BECO’s reputation as a key player in the regional tech ecosystem​. The firm is sector-agnostic, with a particular focus on areas like fintech, SaaS, and logistics, supporting companies from seed to Series B stages. Its mission is to drive innovation across the region while being a supportive partner to founders, helping them achieve global success. BECO Capital’s unique approach combines deep regional knowledge with global insights, making it a crucial contributor to the growth of the MENA startup ecosystem.

Bedrock Capital is a venture capital firm founded by Geoff Lewis, known for its unique investment approach centered around "narrative violations." This concept involves identifying and investing in companies that defy prevailing industry narratives and trends. Bedrock seeks opportunities in technology sectors that are often overlooked or misunderstood by mainstream investors, believing that these areas hold significant potential for groundbreaking innovation. Since its inception in 2018, Bedrock has managed to grow its assets under management to approximately $2 billion. The firm has made notable investments in a variety of companies, including Rippling, OpenAI, and Flock Safety. These companies are recognized for their innovative contributions across different fields, from AI research and HR solutions to public safety technology. Geoff Lewis, the founder and managing partner, has a distinguished career in venture capital, having previously been a partner at Founders Fund. He has led early-stage investments in several high-profile companies such as Lyft, Upstart, and Tilray. Under his leadership, Bedrock continues to focus on identifying and supporting transformative entrepreneurs who challenge the status quo and redefine their industries.

Bee Partners, founded in 2009, is a pre-seed venture capital firm based in San Francisco. The firm focuses on investing in deep tech startups that are at the forefront of human-machine convergence. Their primary areas of investment are Human-Machine Interaction, Machine-to-Machine Learning, and Biological Machines. Notable portfolio companies include Rapid Robotics, which develops AI-powered robots for industrial automation, and InnerPlant, a company that provides plant-based bio-signals for agricultural efficiency. Other significant investments are in companies like Embroker, a commercial insurance platform, and New Culture, which produces animal-free dairy products​​. Bee Partners has been instrumental in supporting innovative startups through early investments and strategic guidance. They have a strong track record of helping their portfolio companies secure follow-on funding from leading venture capital firms​.

BEENEXT, founded in 2015 by Teruhide Sato, is a venture capital firm based in Singapore that focuses on early-stage technology startups in India, Southeast Asia, Japan, and the USA. The firm invests across diverse sectors, including fintech, healthtech, foodtech, and proptech, aiming to support innovative companies that drive significant change. Notable investments include BharatPe, a leading fintech company in India; NoBroker, a proptech platform in India; Trusting Social, an AI-driven fintech firm; M2P, an open banking platform; and Coins.ph, a digital wallet in the Philippines. BEENEXT has made over 317 investments, and the firm is known for its hands-on approach, leveraging the extensive operational experience and global network of its founders to provide strategic support and mentorship to its portfolio companies. This approach has led to several successful exits, such as Dekoruma, an Indonesian e-commerce platform; Milkbasket, an Indian grocery delivery service; and Coins.ph, which was acquired. The firm operates with a philosophy centered on empowering founders and fostering innovation, with the goal of building scalable and sustainable businesses. BEENEXT is particularly focused on identifying startups that have the potential to make a substantial impact in their respective industries. The firm’s extensive network of advisors and partners further strengthens its ability to support portfolio companies through various stages of growth, from initial funding rounds to scaling and eventual exit strategies.

Behind Genius Ventures is a Gen Z-founded venture capital firm backing "technical storytellers" at the pre-seed and seed stages. Launched by Paige Doherty, the firm focuses on the future of work and play, with notable investments in companies like Coastal Carbon, Hearth Display, and Break Sports. These startups span applied AI, sports tech, and environmental solutions. Their geographic focus is on the U.S. and Canada, seeking founders with product-led growth strategies. Behind Genius Ventures is known for moving fast, often making decisions within two weeks. Their average check size is $250K, and they actively lead rounds while adding value beyond capital through partnerships with tech giants like Google Cloud and AWS. The firm is described by founders as "warm and supportive," punching above its weight in helping startups scale through unique partnership initiatives. Founded in 2021, Behind Genius Ventures has already raised $8.9M for its second fund, supported by LPs like Cendana Capital and GREE. With a team that embraces creativity and simplicity, the firm offers startups access to a community-driven support system and resources to help them grow quickly in competitive markets.

Belcorp Ventures is the corporate venture capital arm of Belcorp, a leading Latin American beauty corporation with over 50 years of market history. Founded in 2019 and based in Lima, Peru — with Swiss legal registration as Belcorp Corporate Venture Capital SA — the firm invests in early-stage startups at the intersection of beauty, wellness, and consumer goods. The fund backs passionate founders radically transforming the beauty industry through technology, disruptive business models, and innovation with measurable market impact. Belcorp Ventures targets seed and Series A rounds, with typical checks between $1 million and $10 million, focusing primarily on US-based startups. With four investments to date, the portfolio includes PROVEN, which applies AI to personalized skincare formulation, and PHLUR, a fragrance brand redefining the category for modern consumers. The firm invests alongside strategic alignment with technological megatrends, backing companies with the potential to become market leaders. Belcorp Ventures offers a strategic advantage that is genuinely scarce in the beauty investment landscape: direct access to one of Latin America's largest beauty distribution networks, built over five decades across the region's most important consumer markets. Portfolio companies gain not just capital but a pathway into LATAM markets through Belcorp's established channels, retail relationships, and operational expertise in clinical development and consumer marketing — a combination that few financial investors can replicate in the beauty and wellness sector.

Benchmark Capital is a premier venture capital firm known for its early-stage investments in transformative companies. Notable investments include eBay, Twitter, Uber, Instagram, and Snapchat, showcasing their knack for identifying high-potential startups. They focus on sectors such as social media, mobile technology, cloud computing, and enterprise software, typically investing at the seed and Series A stages. Benchmark primarily operates within the United States, with offices in San Francisco and Menlo Park. Their investment strategy emphasizes hands-on support and close collaboration with entrepreneurs, aiming to drive startups to achieve market leadership. The firm is known for its unique equal partnership model, ensuring that all partners have an equal say in decision-making processes. With an average check size varying from $1 million to $20 million, Benchmark often leads investment rounds, bringing significant value through strategic guidance and robust industry networks. Founders looking to engage with Benchmark should be prepared with a strong vision and the ability to demonstrate potential for large-scale impact. The firm is led by a team of seasoned investors, including partners like Peter Fenton, Bill Gurley, and Sarah Tavel, who bring extensive experience and a track record of successful exits. This powerhouse team leverages their expertise to provide unparalleled support to their portfolio companies, driving innovation and growth across various industries​.

Beringea is a transatlantic venture capital firm with a significant presence in the UK and the US, managing over $900 million in assets. Founded in 1988, Beringea has made a name for itself by investing in high-growth companies across sectors such as healthcare, clean technology, media, consumer services, SaaS, and technology. Notable investments from Beringea include successful exits like D3O, ContactEngine, and Inskin Media, showcasing their ability to nurture and grow impactful businesses. Their portfolio also features promising companies like MPB, Flywheel, Asterra, Moonshot, and Akadeum, which highlight their focus on innovation and scalability. Beringea’s investment strategy involves early and growth-stage funding, with typical investments ranging from $2 million to $10 million. They emphasize scalable business models targeting large markets and have a strong track record of leading funding rounds and providing significant operational support to their portfolio companies. Geographically, Beringea operates out of Farmington Hills, Michigan, and London, with additional offices and operations supporting their global reach. The firm's team includes experienced partners like Michael Gross and Stuart Veale, who bring extensive industry knowledge and leadership to the table.

Berkeley SkyDeck is UC Berkeley's premier startup accelerator, integrating the extensive resources of one of the world's top universities with a robust venture fund. Launched as a partnership between the Haas School of Business, the College of Engineering, and the Office of the Vice Chancellor for Research, SkyDeck combines traditional accelerator consulting with academic expertise and research resources​. The Berkeley SkyDeck Fund, with $85 million under management, invests in startups participating in the accelerator program and those with Berkeley affiliations. Each startup in the accelerator receives an initial investment of $200,000. The fund is known for its high activity, making over 100 investments in just three years, backed by prominent VCs like Sequoia Capital and Mayfield Fund. SkyDeck provides startups with access to a vast network of advisors, industry partners, and UC Berkeley alumni, helping them with sales, hiring, and further financing introductions. This network-driven approach has proven successful for alumni startups like DeepScribe and SuperAnnotate, which have raised significant funds and achieved substantial growth. The accelerator supports a diverse range of startups from various sectors and stages, including biotech, hardware, consumer products, and enterprise solutions. SkyDeck also emphasizes diversity, equity, and inclusion, actively working to support underrepresented founders.

Bessemer Venture Partners (BVP), headquartered in San Francisco, is one of the oldest venture capital firms in the United States. Established in 1911, BVP has a long history of investing in early- and growth-stage companies across various industries, including technology, healthcare, and consumer sectors. Some of their notable investments include Shopify, LinkedIn, DocuSign, Pinterest, and Yelp​. BVP is known for its systematic approach to venture capital, leveraging deep industry insights and a decentralized decision-making process. This allows individual partners significant autonomy to invest across different stages, industries, and geographies. The firm has offices not only in the U.S. but also in India, Israel, and the UK​. BVP has raised multiple funds over the years, including a $3.85 billion early-stage fund in 2021 and a $780 million buyout fund under BVP Forge in 2022. These funds reflect their strategy of supporting startups from inception through to growth and eventual exit​ . Their "Anti-Portfolio" is a unique feature on their website, showcasing major investment opportunities they missed, including companies like Apple and eBay, highlighting their commitment to transparency and learning from past decisions​ ​. With a focus on fostering innovation and supporting dynamic founders, Bessemer Venture Partners continues to be a significant player in the global venture capital landscape.

Beta Boom, headquartered in Salt Lake City, Utah, is a venture capital firm focused on pre-seed and seed investments in startups led by diverse and underrepresented founders. Established in 2017 by Kimmy and Sergio Paluch, Beta Boom prioritizes founders outside of the traditional Silicon Valley ecosystem, particularly women and people of color. The firm invests in companies across various sectors, including digital health, financial technology, education technology, and SaaS. Notable portfolio companies include Canopie, Valhalla Healthcare, and Bolder Money. Beta Boom provides extensive post-investment support, including weekly coaching in product development, marketing, sales, and fundraising, effectively becoming an extension of the startup teams they invest in. Beta Boom recently closed a $14.5 million Fund II, with support from partners such as Ally Bank, Pivotal Ventures, and Bank of America. This fund aims to support early-stage startups addressing the needs of fast-growing yet underserved populations. The firm emphasizes the importance of combining capital with operational expertise to help startups succeed.

B2 Capital, based in London, is a cutting-edge asset management firm that integrates advanced technology and data-driven strategies to revolutionize the fields of ESG (Environmental, Social, and Governance), fintech, supply chain, and inventory finance. With a strong emphasis on innovation, B2 Capital positions itself as a disruptor in these sectors, utilizing a highly scalable tech platform that ensures bank-grade security while delivering agile, international financial solutions. The firm's leadership team brings together over 100 years of combined experience from leading names in the investment and technology sectors. The CEO & Co-CIO, Philip Blows, has a robust background in building and scaling asset management and fintech companies, having previously taken AQRU public in the UK. Co-CIO Dr. Philipp Kallerhoff, with his extensive experience in managing hedge funds and fintech enterprises, adds significant depth to B2 Capital's strategic capabilities. B2 Capital’s investment philosophy is centered around fostering "Diversity of Thought," aiming to deliver excellence to both clients and investors by identifying and funding innovative solutions that address global challenges, particularly in fintech and ESG. The firm’s approach is rooted in a strong commitment to creating the 'what next' in financing solutions, leveraging its advanced infrastructure to disrupt traditional finance models and promote sustainable growth. The firm’s dedication to innovation and its strategic focus on high-impact sectors position B2 Capital as a leader in the next generation of asset management.

Betaworks is a product-focused, seed-stage venture capital firm based in New York City and San Francisco. Founded by John Borthwick, the firm invests in pre-seed and seed-stage startups, typically with check sizes ranging from $250,000 to $750,000. Betaworks is known for its thematic approach, immersing itself in emerging technologies and user behaviors to identify and nurture high-potential startups. Betaworks has built and invested in notable companies such as Giphy, Dots, bitly, Tweetdeck, and Chartbeat. Their investments also include Twitter, Tumblr, Kickstarter, Medium, Hugging Face, and RecRoom. The firm operates Betaworks Camp, a cohort-based investment and product development program that delves into specific tech themes such as AI, gaming, and decentralization. The team at Betaworks includes John Borthwick, Jordan Crook, and Jonathan Chin, among others, who bring extensive experience in technology, media, and venture capital. Betaworks continues to foster innovation through its community-focused initiatives and strategic investments in the latest technological trends.

Betaworks Ventures is a product-focused, seed-stage venture capital firm based in New York City and San Francisco. Founded in 2008, Betaworks Ventures has invested in numerous innovative companies, particularly in the fields of artificial intelligence (AI), machine learning (ML), and software as a service (SaaS). Their typical investment range is between $250,000 and $750,000​​. Some of their notable investments include companies like Giphy, the popular GIF-sharing platform; Hugging Face, known for its AI-driven natural language processing tools; and Stability AI, a leader in generative AI technologies. Betaworks Ventures has also been involved in successful exits such as Shine, an app focused on mental health and wellness, and 8th Wall, a company specializing in augmented reality. Betaworks Ventures is known for its thematic investment approach, often immersing itself in emerging technologies and trends to better understand new user behaviors. This allows them to strategically invest in early-stage startups that are poised to shape the future of their respective industries​. The firm was founded by John Borthwick, who continues to lead the team along with partners like Matt Hartman and Peter Rojas. Their collective expertise and deep involvement in the tech ecosystem enable them to provide not just capital, but also valuable mentorship and support to their portfolio companies​​.

Bethnal Green Ventures (BGV) is Europe's leading early-stage tech-for-good venture capital firm, founded in 2012 and based in London, United Kingdom. The firm invests in ambitious, diverse founders using technology to address significant social and environmental challenges with the goal of improving millions of lives. BGV manages £50 million in assets and supports a portfolio of 75 active companies, having made 25 new programme and follow-on investments in 2024 alone. The firm announced a £33 million first close of a new fund, backed by the British Business Bank and Better Society Capital, to back 100 further tech-for-good startups. BGV's flagship Tech for Good Programme provides initial investments of £60,000 for 7% equity. The firm follows on from pre-seed through Series A and Series B for standout companies demonstrating both commercial traction and impact. The portfolio spans health technology, clean technology and sustainability, and education, with a concentration in software solutions that can be scaled globally. BGV leads rounds and takes an active role in each cohort company from the earliest stages. BGV has been a pioneer in demonstrating that commercial returns and positive social impact are not in conflict in the technology sector. The firm's 13-year track record building the UK and European tech-for-good ecosystem has established its programme as one of the most credible early-stage entry points for mission-driven founders. BGV provides not just capital but structured support, peer networks, and access to a growing community of impact-aligned investors, corporates, and public sector partners.

Better Capital is a global venture capital firm that invests in early-stage startups across a variety of sectors. Founded by Vaibhav Domkundwar, the firm has a robust portfolio with over 200 companies, a combined valuation exceeding $7 billion, and two unicorns. They focus on backing bold innovators from day zero, emphasizing a conviction-driven investment approach. The firm has notable investments in fintech, health tech, SaaS, and digital education, with significant companies like Slice, Open, and Teachmint. Better Capital typically invests in pre-seed and seed rounds, with check sizes ranging from $300K to $1M. Their portfolio also includes companies like Rupeek, Khatabook, and Yulu, which are leaders in their respective fields. Geographically, Better Capital has a strong presence in India and the United States, with investments also spread across Singapore, the UK, and Australia. The team comprises experienced professionals who have founded, grown, and sold tech startups, providing valuable mentorship and support to the companies they invest in. Startups looking to engage with Better Capital should demonstrate innovative solutions with potential for significant impact and growth. The firm values mission-driven founders and aims to support them in creating industry-defining changes.

Better Tomorrow Ventures (BTV) is a San Francisco-based venture capital firm focused on pre-seed and seed-stage investments in fintech companies globally. Founded by Jake Gibson and Sheel Mohnot, BTV leverages their extensive experience and networks in the fintech industry to support startups with ideation, key hires, customer introductions, and fundraising. They lead rounds with check sizes ranging from $500k to $3 million and manage $225 million in assets under management (AUM). BTV has invested in over 100 fintech companies, collaborating with top-tier VCs. Their portfolio includes notable companies like Albert, Lattice, Mercury, Ironclad, Flexport, and Ramp. They emphasize being hands-on partners, offering not just capital but also strategic guidance and operational support to help founders build successful companies. The team at BTV includes experienced operators who have built and exited startups themselves, bringing deep industry knowledge and a passion for fintech. This commitment to early-stage fintech innovation makes BTV a prominent player in the venture capital landscape​.

Better Ventures is a mission-driven VC firm investing in early-stage startups that harness cutting-edge technology to address pressing global challenges. Their notable investments include Meati, a sustainable protein innovator, and SMBX, a platform democratizing business financing. With a focus on sectors like climate tech, human health, and equitable economies, they back diverse teams aligned with the UN's Sustainable Development Goals. Based in Oakland, Better Ventures leads seed rounds, providing active support for founders committed to making a measurable impact. The team looks for companies that can scale profitably while driving social and environmental change, ensuring purpose and profit go hand-in-hand. Better Ventures prefers founders who blend technological innovation with a clear mission. They typically write checks of $500k to $1 million and often lead or co-lead rounds. The firm emphasizes strong partnerships, working closely with founders to scale their impact. Startups should approach Better Ventures with a well-defined purpose, as they prioritize purpose-driven innovation. The founding team includes Rick Moss and Jenny Kassan, both seasoned in impact investing and business development. Better Ventures' geographic focus spans the U.S., especially targeting hubs of innovation. Their approach to funding emphasizes scalability, sustainability, and measurable impact, creating value for both investors and society.

Beyond Next Ventures, founded in 2014 and based in Tokyo, focuses on early-stage investments in deep tech startups, primarily in Japan and India. The firm invests in various sectors including medtech, healthcare, biotechnology, agriculture, food, digital, space, and climate technology​. Notable investments include companies like MediBuddy, GigIndia, QD Laser, and Susmed. MediBuddy is a significant player in telemedicine and healthcare services in India, while QD Laser and Susmed are notable for their IPOs on the Tokyo Stock Exchange​. Beyond Next Ventures typically leads early-stage financing rounds, offering extensive support through their incubator programs aimed at commercializing advanced research. The firm has about $340 million under management, underscoring its commitment to fostering innovation in deep tech and science-based startups​. The leadership team, including CEO Tsuyoshi Ito and Managing Director Kengo Ueha, brings a wealth of experience and strategic insight, supporting startups through growth management, market entry, and expansion strategies.

BGF (Business Growth Fund) is one of the most active equity investors in the UK and Ireland, offering long-term, minority equity investments to ambitious small and mid-sized businesses. Established in 2011, BGF has invested nearly £4 billion across over 900 companies, spanning a wide range of industries, including healthcare, technology, climate sustainability, retail, and advanced manufacturing. Their portfolio includes well-known brands such as Plant-Ex and RSK Group. BGF’s strategy focuses on providing patient capital, meaning they support businesses over the long term without taking a controlling stake. They typically invest between £2 million and £20 million, with the flexibility to provide follow-on funding to drive further growth. BGF is committed to partnering with management teams across the UK and Ireland, using their regional offices to maintain close relationships with portfolio companies. With a significant emphasis on value creation, BGF supports its businesses with expertise in scaling operations, improving governance, and expanding into new markets. Their portfolio spans a wide range of sectors, from deep tech and life sciences to climate-focused companies, reflecting BGF’s commitment to fostering sustainable, scalable growth across the economy.

Bharat Fund, also known as Bharat Innovation Fund, is a venture capital firm based in India that focuses on early-stage investments in deep-tech and IP-driven startups. Founded under the aegis of CIIE.CO at IIM Ahmedabad, the fund aims to support companies that provide innovative solutions in sectors such as healthcare, agriculture, renewable energy, and advanced technology. The fund typically invests in pre-Series A and Series A stages, providing not just capital but also strategic insights, market development support, and access to extensive networks to help startups scale effectively. Bharat Fund’s mission is to back transformative entrepreneurs who are addressing some of the toughest global challenges, with the goal of turning their ventures into globally competitive and disruptive companies. Bharat Fund’s portfolio includes startups that are leveraging technology to create significant impact. By remaining deeply engaged throughout the lifecycle of their investments, Bharat Fund aims to significantly de-risk the conversion of innovative ideas into successful companies. The fund’s name, "Bharat," is inspired by the traditional name for India and reflects their dedication to fostering breakthrough innovations from the country. Their approach combines a decade of early-stage investing experience with support from key partners like Tata Trusts, enabling them to build a robust platform for nurturing high-potential startups.

Bialla Venture Partners (BVP) is a Sausalito, California-based venture capital firm founded in 2015, operating as the investment arm of Bialla and Associates Inc., an executive search and management consulting firm. The firm specializes in startup and early-stage investments, sourcing deals through its executive search network and adding value through direct operational experience and access to management talent. BVP partners with passionate founding teams across software, consumer goods, health, media, e-commerce, fintech, and food. BVP has deployed capital across two funds. Fund I backed companies including ClientSuccess, Five Star Organics, MagicCube, Safe Cash Payment Technologies, Soma Water, and True Botanicals. Fund II investments include Ascent360, Hookit, Retain.ai, Saucey, and True Botanicals, among others. With 27 total investments and checks between $100,000 and $1 million, BVP typically participates at pre-seed and seed stages before institutional venture rounds. Bialla Venture Partners' core competitive advantage is structural: its executive search parent generates proprietary deal flow through relationships with founders, operators, and board members across industries. The same network that surfaces candidates for C-suite roles surfaces early-stage investment opportunities before they reach the broader market. For portfolio companies, BVP leverages this same network to accelerate executive hiring — one of the most common growth constraints for early-stage companies — providing both capital and access to leadership talent from the first investment.

Big Idea Ventures, founded in 2018, is a leading venture capital firm focusing on the alternative protein and food technology sectors. With over 110 early-stage investments, they have become the most active investor in FoodTech globally. The firm operates through its New Protein Fund and Generation Food Rural Partners fund, supporting innovative companies in plant-based, cell-based, and fermentation-enabled food technologies. Notable investments include companies like Naturannova, which creates sustainable peptide-based flavors using AI, and SoundEats, a cultivated seafood pioneer. Other standout portfolio companies are New Wave Biotech, which develops bioprocess optimization software, and Loki Foods, which produces plant-based seafood using renewable energy in Iceland. Big Idea Ventures runs bi-annual accelerator programs in New York, Paris, and Singapore, providing selected companies with a $200,000 investment and access to an extensive network of partners and investors. This hands-on support helps startups navigate product development, scaling, and market entry. Led by founder Andrew D. Ive, Big Idea Ventures collaborates with strategic partners like Temasek Holdings, Tyson Ventures, and Givaudan, aiming to drive significant advancements in food security and sustainability.

Big Pi Ventures is a venture capital firm based in Greece, focusing on seed and early-stage investments, particularly in deep-tech and science-driven startups. Established with a vision to drive transformative innovation, Big Pi partners with exceptional teams developing technologies that address significant global challenges. Their investments span various sectors, including artificial intelligence, health and life sciences, and climate technology, often targeting companies with strong intellectual property or technological advantages. The firm is anchored in Greece but maintains a global perspective, requiring that its portfolio companies establish substantial operations in Greece. Notable investments include companies like TileDB, Orfium, and Navenio, reflecting their commitment to backing ventures that have the potential to scale internationally. Big Pi is led by a team of seasoned entrepreneurs and investors, including Marco Veremis, co-founder of Upstream, and Alex Eleftheriadis, a pioneer in video compression technology. The team offers more than just capital, providing strategic support in areas like product design, scaling, and global market expansion. Their latest rebranding and new fund, announced in 2023, signify their ongoing commitment to fostering innovation and supporting the next generation of tech leaders.

BIGR Ventures, officially known as Boulder Investment Group Reprise, is a growth equity fund that focuses on early-stage investments in the natural and organic products sector. Founded in 2015 and headquartered in Boulder, Colorado, BIGR Ventures is led by a team with over 70 years of combined experience in the natural products industry. The firm is co-managed by Duane Primozich, Carole Buyers, and Bill Weiland, each bringing a wealth of knowledge in business management, brand development, and investment in the natural food and wellness sectors. BIGR Ventures strategically partners with emerging brands that have the potential for significant growth in the natural products space. Their portfolio includes well-known companies such as Bobo’s Oat Bars, High Brew Coffee, RE Botanicals, and Soozy’s Grain-Free, which have benefited from BIGR's extensive industry connections and expertise. The fund's approach emphasizes adding strategic value beyond just capital, helping portfolio companies scale through marketing, distribution, and operational support. The firm has a successful track record, with several notable exits, including REBBL and Suja Juice, which were acquired after achieving substantial market penetration. BIGR's investment philosophy is grounded in its deep understanding of the natural products industry, allowing it to identify and nurture brands that resonate with today’s health-conscious consumers.

BioAdvance is a prominent life sciences venture capital fund based in the mid-Atlantic region, focusing on therapeutics, diagnostics, medical devices, research tools, and health IT. With over 100 investments, they have achieved 23 exits and brought 12 FDA-approved products to market. Their portfolio companies, such as Palvella Therapeutics and Strados Labs, have attracted significant follow-on funding, collectively raising over $4.2 billion. BioAdvance operates as an evergreen fund, enabling continuous reinvestment and long-term partnership with entrepreneurs. The fund emphasizes capital efficiency and works closely with startups to maximize limited resources. Their investment strategy centers on advancing human health technologies with potential for high impact, targeting early-stage companies with scalable innovations. Led by a team of seasoned executives, scientists, and physicians, BioAdvance is collaborative, often playing an active role in company growth and guiding entrepreneurs toward successful exits via IPOs or acquisitions. They prefer to engage with startups that have a strong business case and well-developed pitch, ensuring a strong fit with their mission of improving human health.

Bioeconomy Capital is a San Francisco and Seattle-based venture capital firm founded in 2015. The firm focuses on early-stage investments in biotechnology, life sciences, and sustainability technology. Bioeconomy Capital is driven by the goal of accelerating the biotechnology revolution by supporting companies that are developing critical infrastructure and innovative technologies for the 21st century. With a strong foundation in synthetic biology, Bioeconomy Capital leverages decades of expertise in life sciences and engineering to back startups with transformative potential. The firm’s portfolio includes notable companies such as Zymergen, Riffyn, Synthace, RoosterBio, and Arzeda. Bioeconomy Capital typically invests between $100K and $5M, with a sweet spot of $1.5M per investment. The firm has a global focus, primarily investing in the U.S. but occasionally supporting companies in the U.K. and other regions. Led by managing directors Rob Carlson and Rik Wehbring, Bioeconomy Capital plays a strategic role in helping its portfolio companies navigate the complexities of scaling biotech and sustainability solutions​.

BioGeneration Ventures (BGV) is a prominent venture capital firm based in Naarden, Netherlands, specializing in early-stage European biotech companies. With over €400 million under management, BGV focuses on sectors like biopharma, medtech, and diagnostics. Their portfolio features notable investments in companies such as AcertaPharma, argenx, and New Amsterdam Pharma, underscoring their success in advancing groundbreaking scientific innovations and addressing unmet medical needs. BGV typically engages in seed to early growth stages, strategically guiding companies through clinical trials and drug development to achieve substantial exits. Their rigorous selection process ensures they back ventures with the highest potential for impactful outcomes. BGV's investment philosophy centers on combining deep scientific expertise with commercial insight to build world-class biotech firms. The firm is led by a team of experienced professionals, including managing partners Edward van Wezel and Suzanne Morsink, who bring extensive backgrounds in life sciences and venture capital. They actively support portfolio companies with strategic guidance, leveraging their broad network and industry knowledge to drive growth and innovation. BGV is committed to fostering the next generation of biotech leaders, with a clear focus on creating value for both investors and society by addressing critical health challenges through cutting-edge science and technology

BioMedPartners, through its BioMedInvest funds, focuses on venture capital investments in early to mid-stage companies in the biotechnology, pharmaceutical, and medical technology sectors. Based in Basel, Switzerland, the firm supports innovations primarily in the Alpine region and other European markets. Notable portfolio companies include Aleva Neurotherapeutics, developing next-generation implants for deep brain stimulation; Anergis, which focuses on peptide-based immunotherapies for allergies; and Evolva, a biotech firm creating sustainable ingredients for health and nutrition. Additionally, BioMedPartners has invested in companies like Hookipa Biotech, which develops novel immunotherapies for infectious diseases and cancer, and Sequana Medical, specializing in implantable fluid management systems. The BioMedPartners team is led by General Partners such as Dr. Markus Hosang and Dr. Michael Wacker, who bring extensive experience in drug development, finance, and technology. The firm takes an active role in the development of its portfolio companies, often leading investment rounds and participating as a syndicate partner​.

Bioqube Ventures is a specialist life sciences venture capital firm focused on early-stage investments in Europe, particularly in therapeutic assets and disruptive healthcare technologies. Founded in 2016 by Debora Dumont and Nico Vandervelpen, the firm launched its independent fund, Bioqube Factory Fund I, in 2020. This fund, which has secured over €60 million in its initial closing, aims to support the development of breakthrough therapies by leveraging Bioqube's unique dual investment model. This model includes both traditional venture investments and a "Create" strategy, which focuses on de-risking projects before establishing new ventures. The fund's strategy is deeply rooted in supporting high-potential scientific innovations, transforming them into commercially viable biotechnologies. Bioqube has strong partnerships with prominent investors like the European Investment Fund, Johnson & Johnson Innovation, and Genmab, further bolstering its ability to drive significant advancements in the life sciences sector. The Bioqube team is composed of experienced fund managers, sector experts, and serial entrepreneurs, bringing a hands-on approach to guiding portfolio companies through their growth stages. The firm has a significant presence in Europe, with a focus on regions such as the Benelux, France, and Germany, aiming to build a new generation of leading biotech companies.

BioRock Ventures is a Palo Alto, California-based seed-stage venture capital firm founded in 2019, dedicated to accelerating the development of novel medicines. The firm invests in early-stage biopharmaceutical companies developing novel FDA-regulated therapeutic drugs, covering all disease areas, development stages, and therapeutic modalities. BioRock operates two funds — BioRock Ventures I and Fund II — and leads rounds with checks up to $2 million at angel, seed, and Series A stages. The firm is led by Dr. Mary Wheeler, PhD, MBA, Founding Managing Partner, with over two decades of experience in the therapeutics startup sector. With 15 investments concentrated in biotech and pharma, BioRock's portfolio includes Immusoft (gene-modified B cell therapies for rare diseases), Primmune Therapeutics, and Veana Therapeutics — all working within drug discovery and early-stage clinical development. The firm focuses on companies addressing unmet medical needs with scientifically rigorous approaches, prioritizing therapeutic innovation over platform plays. BioRock Ventures leads its rounds, positioning itself as a conviction-driven, science-first investor at the earliest stages of biopharmaceutical company formation. Dr. Wheeler's deep operating background in therapeutics startups allows the firm to evaluate scientific merit with the rigor of an insider, not just a financial analyst. For founders navigating the early challenges of building biopharma companies — from IND-enabling studies through seed fundraising — BioRock provides both capital and an experienced scientific partner committed to the long development timelines that novel therapeutics require.

Bioverge is a venture capital firm and investment platform specializing in early-stage healthcare startups. Based in San Francisco, Bioverge provides accredited investors with opportunities to invest in innovative healthcare companies that aim to transform the industry. The platform leverages deep domain expertise and a robust network to offer exclusive access to premier healthcare startups, ensuring that investments have both high impact and the potential for significant returns. Bioverge Funds, such as the Bioverge Access Fund, allow investors to diversify their portfolios by investing in a curated selection of healthcare startups through a single investment. These funds provide preferred access to deals, discounted fees, and the benefit of spreading investment risk across multiple companies. Bioverge emphasizes a data-driven investment approach, utilizing AI to select the most promising opportunities in the healthcare sector. Notable investments by Bioverge include companies like Enveda, which focuses on developing next-generation small-molecule therapeutics, and JelikaLite, which has created a non-invasive therapy for children with autism. Bioverge's investment strategy aims to support startups that offer groundbreaking solutions in healthcare, biotechnology, and medical technology. The firm was founded by Neil Littman, who brings extensive experience in healthcare venture capital. Bioverge's mission is to democratize access to high-quality healthcare investments, providing individual investors with the same opportunities as institutional investors.

BIP Ventures, previously known as Panoramic Ventures, is an Atlanta-based VC firm known for its mission of investing in underserved markets and underrepresented founders. With over $550 million in assets under management, BIP Ventures focuses on funding early-stage and growth-stage companies, particularly in the B2B software, healthcare, fintech, and tech-enabled services sectors. The firm takes a unique approach by targeting investments in regions often overlooked by traditional VCs, such as the Southeast and Midwest, and promoting diversity in its portfolio, prioritizing racial and gender inclusion. In addition to capital, BIP Ventures offers strategic support, including talent acquisition, operational scaling, and infrastructure to help portfolio companies grow into market leaders. The team, led by Mark Buffington and Paul Judge, consists of experienced investors and operators who have collectively backed over 200 startups, with several notable exits. The firm is also active in fostering innovation through university partnerships, investing in startups originating from academic institutions. BIP Ventures is known for initiatives like its Startup Showdown pitch competitions, which provide early-stage companies with funding opportunities. Entrepreneurs partnering with BIP Ventures benefit from a hands-on approach, with mentorship and resources to accelerate growth.

Birchmere Ventures is a Pittsburgh, Pennsylvania-based venture capital firm founded in 1996, with an additional office in Palo Alto, California. Over nearly three decades and five funds, the firm has built more than $200 million in assets under management and invested in companies across software, health technology, hardware and robotics, clean technology, communications, and AI. Birchmere's founding thesis — that great companies can start anywhere and the best engineers are not limited to coastal schools — remains central to its identity and deal sourcing strategy. The firm leads rounds from pre-seed through Series A, writing checks between $500,000 and $5 million and making 50 investments to date. Notable exits include Cvent (event management software, IPO), TenMarks (math tutoring, acquired by Amazon), CyOptics (optical integrated circuits, acquired by Avago), Neolinear (EDA software, acquired by Cadence), and FreeMarkets (B2B marketplace, IPO). Recent portfolio additions include Healthie (health and wellness platform), Aspinity (analog machine learning chips), and Eyelevel.ai. Birchmere Ventures emphasizes building high-growth technology companies that deliver positive impact alongside strong returns. The firm's Pittsburgh base gives it both a differentiated perspective on the Midwest and Mid-Atlantic startup ecosystems and a long-standing institutional presence in a region that has produced consequential technology companies across multiple cycles. Its track record of backing companies from Pittsburgh to national and global scale over 30 years provides founders with a partner whose commitment extends well beyond any single fund vintage.

Bitkemy Ventures is a Hyderabad, India-based seed-stage venture capital fund and technology venture builder, founded in 2012. The firm identifies and invests in technology startups with outstanding potential to create consumer value by disrupting traditional industry models and building entirely new ecosystems. Bitkemy targets companies at the pre-seed and seed stages, investing $100,000 to $1 million in India-based startups across SaaS, health technology, fintech, e-commerce, and enterprise software. With 8 investments across its focus sectors, Bitkemy operates as both an investor and a hands-on venture builder, deploying its own technology capabilities alongside capital to support early-stage companies. The firm leads rounds and works closely with founding teams through the critical early stages of product development and market validation. Its dual investor-builder model reflects the reality that many seed-stage Indian startups need more than capital — they need technical co-building capacity to reach the milestones required for the next funding round. Bitkemy Ventures is positioned within the Indian startup ecosystem in Hyderabad, one of India's major technology cities, providing local market knowledge and operational connectivity to a growing regional entrepreneur community. The firm's focus on SaaS, healthtech, and fintech reflects the sectors where Indian startups have demonstrated the strongest product-market fit in domestic and export markets. For early-stage founders seeking a technically capable investor who will engage directly with product and engineering challenges, Bitkemy's venture builder model offers an uncommon combination of capital and co-creation.

Bitkraft Ventures is a leading venture capital firm focused on gaming, esports, and interactive media. Founded in 2015 by Jens Hilgers, Bitkraft has established itself as a pioneer in the gaming and Web3 investment space. The firm invests globally, targeting early-stage companies from Seed to Series B rounds. Bitkraft's portfolio includes over 135 companies spanning six continents, with notable investments in startups like Flock Freight, FitXR, and Honeybee Health. The firm's latest fund, Bitkraft Venture Fund 3, has raised $275 million to continue supporting innovative gaming and interactive media companies. Bitkraft's investment strategy emphasizes the convergence of physical and digital worlds, a concept they refer to as "Synthetic Reality." This vision encompasses advancements in AI, VR/AR, and blockchain technologies, aiming to create immersive and interconnected experiences. The team at Bitkraft is comprised of experienced entrepreneurs and industry leaders, providing both capital and strategic guidance to their portfolio companies. With a global presence and deep industry connections, Bitkraft Ventures remains at the forefront of driving innovation in gaming and interactive media.

Bits x Bites is a Shanghai-based venture capital firm and China’s first dedicated agrifood tech investor. Founded in 2016 by Matilda Ho, the firm focuses on early-stage startups tackling the most critical challenges in the food system, including food security, safety, and sustainability. Their investments span the entire food supply chain, from farm innovations to novel food production technologies, helping to revolutionize agriculture in China and beyond. Bits x Bites manages over $100 million across its funds, with a strong emphasis on scalable technologies that can make a measurable impact on food production and environmental sustainability. Their portfolio includes companies like EAVision, which specializes in autonomous drones for complex farming terrains, and Mojia Bio, a biomanufacturing startup that produces eco-friendly nutrients for the food industry. These investments reflect the firm’s commitment to advancing solutions in precision agriculture, alternative proteins, and biomanufacturing. With a global outlook, Bits x Bites evaluates around 1,200 startups annually, targeting companies with technologies that can be applied in China. They support their portfolio companies through partnerships with industry leaders such as Syngenta and Temasek, offering access to valuable resources and markets. The firm’s multidisciplinary team of experts provides hands-on guidance to help startups scale and commercialize their innovations in the Chinese market, shaping the future of food technology in the region​.